The global oncology therapeutics industry continues to expand as healthcare systems prioritize advanced cancer treatment solutions and improved patient survival rates. Increasing awareness regarding early cancer diagnosis, rising investments in pharmaceutical research, and the growing adoption of combination chemotherapy regimens are contributing to significant industry expansion across...

The global oncology therapeutics industry continues to expand as healthcare systems prioritize advanced cancer treatment solutions and improved patient survival rates. Increasing awareness regarding early cancer diagnosis, rising investments in pharmaceutical research, and the growing adoption of combination chemotherapy regimens are contributing to significant industry expansion across...

Combination investigation expanding trifluridine-tipiracil's clinical frontier — the systematic clinical investigation of trifluridine-tipiracil in combinations with immunotherapy (pembrolizumab, nivolumab), targeted therapy (ramucirumab, bevacizumab — validated), PARP inhibitors, and novel agents representing the research pipeline that could substantially expand...